The CLL12 Trial: Ibrutinib Vs Placebo in Treatment-Naïve, Early-Stage Chronic Lymphocytic Leukemia.
Petra Langerbeins,Can Zhang,Sandra Robrecht,Paula Cramer,Moritz Fuerstenau,Othman Al-Sawaf,Julia von Tresckow,Anna-Maria Fink,Karl-Anton Kreuzer,Ursula Vehling-Kaiser,Eugen Tausch,Lothar Mueller,Michael Josef Eckart,Rudolf Schlag,Werner Freier,Tobias Gaska,Christina Balser,Marcel Reiser,Martina Stauch,Clemens-Martin Wendtner,Kirsten Fischer,Stephan Stilgenbauer,Barbara Eichhorst,Michael Hallek Blood（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper